MARKET

FBLG

FBLG

Fibrobiologics
NASDAQ
0.2535
-0.0012
-0.47%
Opening 15:16 02/12 EST
OPEN
0.2582
PREV CLOSE
0.2547
HIGH
0.2621
LOW
0.2405
VOLUME
253.08K
TURNOVER
--
52 WEEK HIGH
1.980
52 WEEK LOW
0.2201
MARKET CAP
16.86M
P/E (TTM)
-0.5271
1D
5D
1M
3M
1Y
5Y
1D
FibroBiologics CEO Pete O’Heeron to Speak at A4LI’s H-SPAN Summit at Georgetown University
Reuters · 2d ago
Weekly Report: what happened at FBLG last week (0202-0206)?
Weekly Report · 3d ago
FibroBiologics Faces Nasdaq Delisting Review After Noncompliance
TipRanks · 6d ago
FibroBiologics droht Nasdaq-Delisting wegen Nichteinhaltung von Börsenauflagen
Reuters · 6d ago
FibroBiologics Faces Nasdaq Delisting Over Market Value and Bid Price Deficiencies
Reuters · 6d ago
FibroBiologics issued Canadian patent covering treatment of Cachexia
TipRanks · 02/05 13:40
FibroBiologics Issued Canadian IP Office Patent
Benzinga · 02/05 13:38
FibroBiologics Granted Canadian Patent for Novel Fibroblast-Based Cachexia Treatment
Reuters · 02/05 13:30
More
About FBLG
FibroBiologics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including wound healing, multiple sclerosis, degenerative disc disease, psoriasis and certain cancers, and potential human longevity applications including thymic involution reversal. Its product candidates include CybroCell, CYMS101 and CYWC628. CybroCell is an allogeneic fibroblast cell-based therapy for degenerative disc disease. This technology is being designed as an alternative method for repairing the cartilage of the intervertebral disc (or any other articular cartilage). It is developing CYMS101 as an allogeneic fibroblast cell-based therapy to treat multiple sclerosis (MS) and has completed the Phase I study. It is developing CYWC628 as an allogeneic fibroblast cell-based therapy for wound healing. Its CYPS317 is used for the treatment of Psoriasis.

Webull offers Fibrobiologics Inc stock information, including NASDAQ: FBLG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FBLG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FBLG stock methods without spending real money on the virtual paper trading platform.